U.S. Cosmetic Labeling for K-Beauty Brands: 10 Mistakes to Avoid

U.S. cosmetic labeling review for K-beauty products


Packaging is one of K-beauty’s strengths, but a visually impressive Korean package is not automatically ready for U.S. sale. American cosmetic labels operate under the Federal Food, Drug, and Cosmetic Act, the Fair Packaging and Labeling Act, and related regulations. Imported products must meet the same applicable U.S. requirements as domestic products.

Labeling includes more than the printed container. FDA’s definition can reach written, printed, or graphic materials accompanying the product, while claims across websites and retail pages can affect intended use. The most efficient approach is to build a U.S. label from a verified compliance checklist before artwork is finalized. The following ten mistakes are common and preventable.

1. Translating the Korean Package Without Rebuilding the Information Hierarchy

Translation may preserve the wrong hierarchy. The principal display panel generally needs product identity and an accurate net-quantity statement. Other required information must be prominent and conspicuous on an appropriate information panel. A literal translation can leave key information too small, hidden, or scattered.

Create an English content matrix first. Assign every required statement to a panel and confirm type size, contrast, placement, and available area before design approval.

2. Using a Product Name That Does Not Clearly Identify Its Nature

A creative name may not tell an American shopper whether the item is a cleanser, serum, mask, cream, or another product. The label should identify the nature or use through an appropriate statement of identity. Do not depend on imagery that only insiders understand.

Test the front panel with someone unfamiliar with the brand. If the product type is unclear without opening a retailer page, the identity needs improvement.

3. Formatting Net Contents Incorrectly

Net quantity belongs on the principal display panel and must use appropriate U.S. customary and metric expressions where required. Conversion, rounding, type size, and placement need review. A sticker added at the last moment can cover artwork or fail prominence rules.

Confirm the actual fill, declared amount, package area, and unit format. Coordinate quality, legal, and design teams so that the statement matches manufacturing specifications.

4. Treating the Ingredient List as a Marketing Paragraph

Retail cosmetics generally require an ingredient declaration using appropriate names and order. Ingredients are usually listed in descending order of predominance, with specific rules for ingredients at one percent or less and color additives. Decorative descriptions, Korean nicknames, or supplier trade names may not be suitable declarations.

Build the list from the final manufacturing formula, not an early sales sheet. Review fragrance, color additives, botanical naming, and multi-component raw materials. Freeze artwork only after formula approval.

5. Making Drug Claims on a Cosmetic Label

Claims to treat or prevent disease or affect the structure or function of the body can make a product a drug. Words such as heals, treats acne, repairs eczema, stimulates collagen production, or regenerates cells can create risk depending on context. A disclaimer does not automatically neutralize a strong therapeutic claim.

Review front panel, carton, insert, website, retailer copy, social briefs, and before-and-after captions as one claim system. Use accurate cosmetic language about appearance, cleansing, moisturizing, conditioning, and feel when supported.

6. Claiming or Implying FDA Approval

Ordinary cosmetics and their labels are not generally pre-approved by FDA, except that color additives have specific approval requirements. MoCRA facility registration and product listing do not equal product approval and should not be advertised as certificates.

Remove seals or statements that could imply government endorsement. Train distributors so that inaccurate “FDA certified” language does not appear on marketplace pages.

7. Omitting Responsible-Party and Adverse-Event Contact Information

The label needs the name and place of business information required by applicable law, and MoCRA requires a domestic address, domestic phone number, or electronic contact through which adverse-event reports can be received. The contact must lead to a functioning process.

Test the email, web form, phone routing, and escalation workflow before launch. Customer service should preserve lot, use, symptom, and contact information needed for follow-up.

8. Forgetting Warnings and Directions for Safe Use

Some products need specific warnings, and a cosmetic that may be hazardous when misused needs appropriate caution and directions. Flammable products, aerosols, eye-area products, and certain acids can require particular attention.

Risk assessment should drive the warning review. Do not copy a competitor’s caution without understanding why it applies. Directions must be realistic, readable, and consistent with safety substantiation.

9. Using English That Is Technically Present but Not Conspicuous

Required information must be readable under customary purchase conditions. Tiny text, low contrast, reflective foil, curved surfaces, and removable sleeves can defeat prominence. Required statements generally need English, even when Korean text is retained for brand identity.

Print physical proofs at final size. Review the label under normal light, on the actual container, and after packaging assembly. Digital zoom can hide real-world readability problems.

10. Failing to Control Changes Across Channels

A compliant carton does not solve an outdated marketplace listing or an influencer script making unauthorized claims. Formula changes can also leave old ingredient images online. Every channel should receive approved current assets.

Use version numbers, approval dates, and an asset repository. Define who can change retailer copy and how quickly outdated content must be removed. Keep evidence for claims linked to the approved wording.

A Pre-Print Review Workflow

  1. Confirm product classification and intended use.
  2. Lock the manufacturing formula and raw-material identities.
  3. Create the ingredient declaration from controlled data.
  4. Map principal and information panel requirements.
  5. Verify statement of identity and net contents.
  6. Review responsible-party and adverse-event contact details.
  7. Assess warnings, directions, and language prominence.
  8. Review all claims across package and digital channels.
  9. Print and inspect a physical final-size proof.
  10. Approve a controlled artwork version and transition plan.

Special Considerations for Small Packages

Eye products, lip items, and samples can have limited space, but small size does not mean requirements disappear. FDA regulations provide specific approaches and type-size provisions for limited package area. Explore cartons, firmly affixed tags, or other compliant structures early rather than shrinking text after design completion.

Samples used in promotions need review too. Whether an item is sold, given away, or used as a tester can affect the practical label plan, and claims still matter.

Localization Beyond Compliance

A compliant label can still confuse customers. Add clear usage order, texture expectations, and routine compatibility where space allows. Explain Korean category terms in familiar English. Avoid cultural references that require background knowledge to understand the product’s basic function.

Good localization reduces customer questions and returns. It also gives retailers confidence that the brand can support American shoppers after the first sale.

Risks and Limitations

This article is general information and does not replace review by qualified U.S. counsel or regulatory professionals. Product facts, package size, claims, color additives, drug status, and distribution model can change the analysis. Rules and FDA guidance should be checked in their current form before printing.

Conclusion and Key Takeaways

Most labeling problems are cheaper to prevent than to correct after inventory arrives. Korean brands should rebuild the U.S. information hierarchy, verify the final ingredient declaration, control claims, provide functioning contact information, and review physical readability.

The strongest label is both compliant and useful. It tells the shopper what the product is, how to use it, what is inside, what to watch for, and who stands behind it. That clarity supports regulatory readiness, retailer confidence, and long-term brand trust.

Sources

Related Posts